Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
Measuring quality of care in the anti neutrophil cytoplasm antibody (ANCA) associated vasculitides (AAV) has become more complex, because the introduction of immunosuppressive therapy has resulted in a substantial improvement in survival. Early diagnosis remains a problem, because many patients are...
Egile Nagusiak: | Mukhtyar, C, Luqmani, R |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2007
|
Antzeko izenburuak
-
Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
nork: Mukhtyar, C, et al.
Argitaratua: (2008) -
Eular recommendations for vasculitis
nork: Luqmani, R, et al.
Argitaratua: (2007) -
Cardiovascular outcomes in ANCA associated vasculitis
nork: Mukhtyar, C, et al.
Argitaratua: (2008) -
Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
nork: Mukhtyar, C, et al.
Argitaratua: (2007) -
Cardiovascular involvement in primary systemic vasculitis.
nork: Mukhtyar, C, et al.
Argitaratua: (2009)